Efikasi gefitinib dan erlotinib pada pasien adenokarsinoma paru dengan mutasi gen epidermal growth factor receptor di Rumah Sakit Rujukan Respirasi Nasional Persahabatan Jakarta = Efficacy of gefitinib and erlotinib for lung adenocarcinoma with epidermal growth factor receptor mutation in Persahabatan Hospital Jakarta

Profil efikasi dan toksisitas terapi target baru golongan Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor (EGFR-TKi) pada pasien kanker paru karsinoma bukan sel kecil non skuamosa dengan mutasi EGFR positif dibandingkan dengan kemoradioterapi pada EGFR Wild type = Profile of efficacy and toxicity the new targeted therapy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKi) in non small cell lung cancer non squamous with mutated EGFR compared with chemoradiotherapy in wild type

Efikasi dan toksisiti erlotinib/gefitinib sebagai terapi lini kedua pada pasien kanker paru jenis karsinoma bukan sel kecil = Efficacy and toxicity erlotinib/gefitinib as second line therapi in non small cell lung cancer patients

Peran Quiescent Lung Cancer Stem Cell (CSC) dalam Prosesresistans terhadap Agen Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI) pada Adenokarsinoma Paru dengan Mutasi EGFR Positif = Role of Quiescent Lung Cancer Stem Cells in Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor (EGFR- TKI) Resistance in EGFR-Mutant Lung Adenocarcinoma

Perbandingan efikasi dan toksisitas hematologi kemoterapi lini i kanker paru karsinoma bukan sel kecil (kpkbsk) jenis karsinoma sel skuamosa (kss) dengan adenokarsinoma egfr wild type di rsup persahabatan = The comparison of efficacy and hematological toxicity of first line chemotherapy of non small cell lung cancer (nsclc) in squamous cell carcinoma (scc) and egfr-wild type adenocarcinoma in persahabatan hospital-Jakarta